GET DAILY SIGNALSCBRS: Analyst Targets Point to +156% Upside from Current Levels
Key Takeaways
- The central target of $250 used here is the arithmetic mean of recent, verifiable sell-side price targets from roughly eight firms, rounded from an underlying average near $248.
- With Cerebras Systems (CBRS) trading around $97.75, reaching $250 would require a gain of roughly 156%, a very large move by any standard.
- Individual 12-month analyst targets span a wide range, from about $178 to $325 (with a few earlier, since-cut targets near $340), reflecting sharp disagreement about the company's outlook.
- The strongest supports are explosive AI-infrastructure revenue growth and a marquee customer relationship with OpenAI, while the biggest risks are widening losses, heavy customer concentration, and a sharp valuation reset in AI hardware.
- Targets have been cut aggressively in recent weeks, yet nearly every analyst retains a Buy or Outperform rating even as the stock trades far below its $386.34 52-week high.
- For more detail on the company's Major News, Today's Price Move, Forecast, and Earnings, explore the dedicated pages.
- Readers can also explore Trending AI Robots to see AI-driven trading strategies currently in focus.
Analyst Price Targets and Consensus View
Cerebras Systems, Inc. is a Sunnyvale, California-based artificial intelligence infrastructure company best known for its wafer-scale engine (WSE) chips, which compete with GPU-based systems for AI inference and training workloads. Because it remains unprofitable, the stock is evaluated primarily on revenue growth, customer concentration, and its long-term technology roadmap rather than traditional earnings multiples.
Reviewing recent, attributed targets shows how much the Street's enthusiasm has cooled even as ratings stay bullish. Morgan Stanley's Joseph Moore kept an Overweight rating but cut his target to $178 from $279; Wedbush's Matt Bryson reiterated Outperform while lowering his target to $190 from $290; and UBS trimmed its target to $250 from $330. Other targets reviewed include Barclays at $280, Mizuho at $300, Needham at $300, Freedom Capital Markets at $209, and TD Cowen at $275. The arithmetic mean of these most recent figures is approximately $248, which rounds to the $250 central target used throughout this article.
The wide spread — roughly $178 to $325 — reflects genuine disagreement. Cautious analysts argue that valuation compression across AI hardware and questions about the longevity of the WSE architecture justify lower multiples, while more optimistic analysts point to a first-mover advantage in "fast inference" and a contracted pipeline that provides multi-year revenue visibility. This $250 figure is a calculated mean of individual targets, not an officially published consensus. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Current Market Position and Path Toward the Target
Shares closed at about $97.75, down sharply from a 52-week high of $386.34 reached in May 2026 but well above the $77.84 low touched in early November 2026. Reaching $250 would require an advance of roughly 156%, which qualifies as a very large move. The stock sits far below its 20-day and 60-day moving averages, indicating the near-term trend has been decisively lower despite a recent bounce.
The path toward a materially higher price would likely need to run through several milestones: continued triple-digit percentage revenue growth, evidence that the OpenAI relationship is expanding rather than merely stable, progress toward profitability or at least narrowing losses, and a stabilization in AI-hardware valuations after a sharp sector-wide reset.
Bullish Drivers That Could Push Shares Higher
The core bull case rests on extraordinary top-line growth. Revenue in the company's most recent reported quarter rose roughly 74% year over year, and analysts continue to describe Cerebras Systems as a leader in fast inference for agentic AI applications. A long-term agreement with OpenAI is central to the thesis, potentially insulating a meaningful portion of future revenue. A recent selection to power Bilt's AI platform, announced in November 2026, illustrates demand beyond the anchor customer. If execution on the next-generation CS-4 platform meets expectations and losses narrow, the valuation could re-rate upward.
Key Risks Standing in the Way
The obstacles are equally significant. The company is loss-making, with a wide GAAP net loss and negative EPS (earnings per share), meaning the stock carries no conventional earnings support at current levels. Revenue concentration in OpenAI is a double-edged sword, and analysts have explicitly flagged investor doubts about the durability of the WSE chips, depreciation practices, and the sustainability of data-center spending. A continued valuation reset in semiconductors, further guidance misses, or any sign of weakening demand for high-speed inference could keep the stock well below its former highs.
Technical Levels and Market Structure
From a technical standpoint, the $77–$78 zone, anchored by the November 2026 low, is the most important nearby support. The psychologically significant $100 level and the area near $108 (the 20-day moving average) represent near-term resistance, while the 60-day moving average near $160 marks a larger recovery hurdle. The stock remains in a long-term downtrend from its $386 peak, so any sustained move toward $250 would first require reclaiming these intermediate levels and establishing a durable base.
Time Horizon and What Investors Should Monitor
Analyst price targets generally reflect a research horizon of about 12 months, though the rapid pace of target revisions around the company shows how quickly those views can shift. Investors should watch quarterly earnings and guidance, any updates to the OpenAI agreement, progress on the CS-4 platform, new customer wins, and changes in analyst targets. Macroeconomic signals — particularly data-center capital spending and interest-rate policy from the Federal Reserve — also matter for a high-multiple, growth-oriented AI name.
How Tickeron’s AI Daily Buy/Sell Signals Fit Into My Process
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile name like Cerebras Systems, such tools can help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual chart review alone. I find it useful to cross-reference these signals when evaluating names with wide analyst target spreads like this one.
Final Assessment
Reaching $250 from roughly $97.75 would require a gain of about 156%, a very large move that would demand sustained execution, an intact OpenAI relationship, and a meaningful recovery in AI-hardware sentiment. The central target reflects the mean of recent analyst targets that still sit far above the market price, underscoring the gap between Wall Street's long-term optimism and the market's current caution. Strong revenue growth and a leadership position in fast inference support the upside, while widening losses, customer concentration, and a brutal valuation reset weigh on the near term. The coming quarters of revenue, guidance, and analyst revisions will determine whether the stock can begin closing that gap.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CBRS's RSI Indicator stays in oversold zone for 5 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 4 of 5 cases where CBRS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for CBRS just turned positive on November 09, 2026. Looking at past instances where CBRS's MACD turned positive, the stock continued to rise in 2 of 2 cases over the following month. The odds of a continued upward trend are 90%.
Following a +18.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBRS advanced for three days, in 17 of 22 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBRS entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.327) is normal, around the industry mean (5.443). P/E Ratio (-19.264) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry Semiconductors
Advertisement